Millennium Velcade Multiple Myeloma Launch Expected In Late 2003

Millennium expects FDA approval of the proteasome inhibitorVelcade for multiple myeloma in the second half of 2003 based on Phase II data

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet